optoCAR

OptoCAR is described in the supplied research summary as an optically controllable antigen receptor used to analyze signaling behavior and tune CAR activation. It fits the review's focus on optical control of T cell signaling.

optoCAR is described in the supplied evidence as an optogenetic antigen-receptor tool for controlling T-cell signaling with light. It is relevant to studying and tuning temporal activation dynamics in T cells.

It requires engineered CAR constructs with photoswitchable or light-responsive modules. The abstract does not provide exact implementation details.

The available evidence supports that optoCAR requires engineered T cells carrying a light-responsive receptor design and an illumination regime. Specific components are not given in the anchor abstract.

It helps control and interrogate CAR signaling with temporal precision.

It addresses the need to control when and how strongly engineered T cells are stimulated, which can help probe molecular rationale behind therapy success.

The provided evidence does not establish that it solves downstream therapeutic delivery or all safety constraints.

The provided review-level evidence does not show that optoCAR resolves all therapeutic limitations of ATC, especially solid-tumour failure modes.

The supplied research summary points to LiCAR and opto-ligand-TCR as related optical-control systems.

The supplied evidence places optoCAR alongside LiCAR and the LiTE system as related optogenetic approaches for controlling T-cell activation.